Douglas J Sheffler

Title: Douglas J. Sheffler: Innovator in GlyT1 Inhibitors

Introduction

Douglas J. Sheffler is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of GlyT1 inhibitors. With a total of 5 patents to his name, Sheffler's work focuses on innovative compounds that target glycine type 1 transporter (GlyT1) activity.

Latest Patents

Among his latest patents, Sheffler has developed the following notable inventions:

1. **3.1.0 Bicyclic GlyT1 Inhibitors and Methods of Making and Using Same** - This invention relates to compounds that serve as inhibitors of GlyT1 activity. It includes synthetic methods for creating these compounds, pharmaceutical compositions that incorporate them, and methods for treating disorders linked to GlyT1 activity.

2. **Sulfonyl-Piperidin-4-yl Methylamine Amide Analogs as GlyT1 Inhibitors** - Similar to his previous work, this invention focuses on compounds that inhibit GlyT1 activity. It also details synthetic methods for their production, pharmaceutical compositions, and treatment methods for psychiatric disorders associated with GlyT1 activity.

Career Highlights

Douglas J. Sheffler is affiliated with Vanderbilt University, where he continues to advance research in the field of pharmacology. His innovative work has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Sheffler has collaborated with notable colleagues such as Craig William Lindsley and P. Jeffrey Conn. Their joint efforts have contributed to the advancement of research in GlyT1 inhibitors and their potential applications.

Conclusion

Douglas J. Sheffler's contributions to the field of GlyT1 inhibitors highlight his role as an influential inventor. His work not only advances scientific understanding but also holds promise for the treatment of various disorders.